title: Continuous bioprocessing: the real thing this time? 10(th) Annual bioProcessUK Conference, December 3-4, 2013, London, UK.
abstract: The Annual bioProcessUK Conference has acted as the key networking event for bioprocess scientists and engineers in the UK for the past 10 years. The following article is a report from the sessions that focused on continuous bioprocessing during the 10(th) Annual bioProcessUK Conference (London, December 2013). These sessions were organized by the 'EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies' hosted at University College London. A plenary lecture and workshop provided a forum for participants to debate topical issues in roundtable discussions with industry and academic experts from institutions such as Genzyme, Janssen, Novo Nordisk, Pfizer, Merck, GE Healthcare and University College London. The aim of these particular sessions was to understand better the challenges and opportunities for continuous bioprocessing in the bioprocessing sector.
authors.affiliation: a Department of Biochemical Engineering ; University College London; Gordon Street , London , UK.
authors.forename: Suzanne S
authors.initials: SS
authors.lastname: Farid
authors.forename: Bill
authors.initials: B
authors.lastname: Thompson
authors.forename: Andrew
authors.initials: A
authors.lastname: Davidson
mesh_terms: D001702:Biopharmaceutics / Q000379:methods* / Q000639:trends; D001709:Biotechnology / Q000379:methods* / Q000639:trends; D004345:Drug Industry / Q000379:methods / Q000639:trends; D006801:Humans; D013678:Technology, Pharmaceutical / Q000379:methods / Q000639:trends
keywords: Biopharmaceutical manufacture; cell culture; continuous bioprocessing; continuous chromatography; fed-batch; perfusion; process economics